These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 27128373)
21. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis. Castello MA; Soriano S Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390 [TBL] [Abstract][Full Text] [Related]
22. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease. Bales KR Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752 [TBL] [Abstract][Full Text] [Related]
23. Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease. Torres M; Price SL; Fiol-Deroque MA; Marcilla-Etxenike A; Ahyayauch H; Barceló-Coblijn G; Terés S; Katsouri L; Ordinas M; López DJ; Ibarguren M; Goñi FM; Busquets X; Vitorica J; Sastre M; Escribá PV Biochim Biophys Acta; 2014 Jun; 1838(6):1680-92. PubMed ID: 24374316 [TBL] [Abstract][Full Text] [Related]
24. Lipid Profiling of Alzheimer's Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism. Akyol S; Ugur Z; Yilmaz A; Ustun I; Gorti SKK; Oh K; McGuinness B; Passmore P; Kehoe PG; Maddens ME; Green BD; Graham SF Cells; 2021 Sep; 10(10):. PubMed ID: 34685570 [TBL] [Abstract][Full Text] [Related]
25. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis. Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423 [TBL] [Abstract][Full Text] [Related]
32. Lipids and Alzheimer's Disease. Kao YC; Ho PC; Tu YK; Jou IM; Tsai KJ Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098382 [TBL] [Abstract][Full Text] [Related]
33. Lipids and the pathogenesis of Alzheimer's disease: is there a link? Mielke MM; Lyketsos CG Int Rev Psychiatry; 2006 Apr; 18(2):173-86. PubMed ID: 16777671 [TBL] [Abstract][Full Text] [Related]
34. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease. Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268 [TBL] [Abstract][Full Text] [Related]
35. ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-β Pathology. Zhao QF; Wan Y; Wang HF; Sun FR; Hao XK; Tan MS; Tan CC; Zhang DQ; Tan L; Yu JT; J Alzheimers Dis; 2016 Mar; 52(2):693-703. PubMed ID: 27003212 [TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E and Alzheimer disease. Huang Y Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152 [TBL] [Abstract][Full Text] [Related]
37. Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes. Cossec JC; Marquer C; Panchal M; Lazar AN; Duyckaerts C; Potier MC Biochim Biophys Acta; 2010 Aug; 1801(8):839-45. PubMed ID: 20348021 [TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease. Liao F; Yoon H; Kim J Curr Opin Lipidol; 2017 Feb; 28(1):60-67. PubMed ID: 27922847 [TBL] [Abstract][Full Text] [Related]
40. Fatty acids and beyond: Age and Alzheimer's disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition. Ooi KM; Vacy K; Boon WC Neurochem Int; 2021 Oct; 149():105143. PubMed ID: 34311029 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]